Phase 4 HER2-negative Clinical Trials

5 recruitingPhase 4

What is a Phase 4 trial?

Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.

Showing 1–5 of 5 trials

Recruiting

Phase 4

Intrathecal Chemotherapy Through Ommaya Reservoir Upon Her-2 Negative Breast Cancer With Leptomeningeal Metastasis

HER2-negative Breast CancerLeptomeningeal Metastasis

Fudan University37 enrolled1 locationNCT06230055

Recruiting

Phase 4

OFS in Premenopausal Node+ Breast Cancer With Low Genomic Risk

Breast CancerNode-positive Breast CancerHER2-negative Breast Cancer+2 more

Gangnam Severance Hospital418 enrolled2 locationsNCT05333328

Recruiting

Phase 4

Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect Management

Hormone Receptor-positive Metastatic Breast CancerHER2-negative Metastatic Breast Cancer

Prof. Wolfgang Janni300 enrolled54 locationsNCT05362760

Recruiting

Phase 4

Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer Patients

Breast CancerBreast Cancer FemaleBreast Neoplasms+2 more

Institut fuer Frauengesundheit1,000 enrolled52 locationsNCT05452213

Recruiting

Phase 4

Select the Appropriate Population for Adding CDK4/6i to Neoadjuvant Endocrine Therapy

Locally Advanced Breast CancerHormone Receptor Positive，HER2-negative Breast Cancer

Yongsheng Wang100 enrolled1 locationNCT05809024